January 11, 2019
Chugai Pharmaceutical’s cancer drug Avastin (bevacizumab) was the best-selling drug in Japan in December with 10.1 billion yen on an NHI price basis, according to a monthly snapshot report released by market research firm Encise. Avastin was followed by Pfizer’s...read more